These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 8509626
21. Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). Samuel D, Forns X, Berenguer M, Trautwein C, Burroughs A, Rizzetto M, Trepo C. J Hepatol; 2006 Jul; 45(1):127-43. PubMed ID: 16723165 [No Abstract] [Full Text] [Related]
22. [Liver transplantation for patients infected with both HIV and HCV or HIV and HBV]. Duclos-Vallée JC, Teicher E, Vittecoq D, Samuel D. Med Sci (Paris); 2007 Jul; 23(8-9):723-8. PubMed ID: 17875290 [Abstract] [Full Text] [Related]
23. [Risks and prevention in orthotopic liver transplantation and persistent infection with hepatitis type B and type delta viruses]. Hopf U, Neuhaus P, König V, Bauditz J, Küther S, Schmidt CA, Steffen R, Blumhardt G, Bechstein WO, Neuhaus R. Z Arztl Fortbild (Jena); 1992 Sep 10; 86(17):861-8. PubMed ID: 1413903 [No Abstract] [Full Text] [Related]
25. Hepatitis C and B in liver transplantation. Lake JR, Wright T, Ferrell L, Donegan E, Roberts J, Ascher N. Transplant Proc; 1993 Apr 10; 25(2):2006-9. PubMed ID: 8470258 [Abstract] [Full Text] [Related]
26. Hepatitis B and C in the liver transplant recipient: current understanding and treatment. Rosen HR. Liver Transpl; 2001 Nov 10; 7(11 Suppl 1):S87-98. PubMed ID: 11689781 [Abstract] [Full Text] [Related]
27. [Liver transplantation in patients with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus]. Duclos-Vallée JC, Roche B, Samuel D. Presse Med; 2009 Sep 10; 38(9):1281-9. PubMed ID: 19574023 [Abstract] [Full Text] [Related]
30. Liver transplant for viral hepatitis. Recurrence of reinfection. Smedile A, Marzano A, Farci P, Chiaberge E, Abate M, Ottobrelli A, Brunetto MR, Rosina F, Durazzo M, Verme G. J Hepatol; 1991 Sep 10; 13 Suppl 4():S134-7. PubMed ID: 1822508 [No Abstract] [Full Text] [Related]
31. High-rate hepatitis and low-rate rejection induced late morbidity and mortality in long-term follow-up after liver transplantation. Caccamo L, Rossi G, Gridelli B, Maggi U, Reggiani P, Colledan M, Fassati LR. Transplant Proc; 1998 Aug 10; 30(5):1828-9. PubMed ID: 9723298 [No Abstract] [Full Text] [Related]
35. Outcome of orthotopic liver transplantation in patients with haemophilia. Gordon FH, Mistry PK, Sabin CA, Lee CA. Gut; 1998 May 10; 42(5):744-9. PubMed ID: 9659174 [Abstract] [Full Text] [Related]
36. How to improve long-term outcome after liver transplantation? Durand F. Liver Int; 2018 Feb 10; 38 Suppl 1():134-138. PubMed ID: 29427483 [Abstract] [Full Text] [Related]
37. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. Marzano A, Gaia S, Ghisetti V, Carenzi S, Premoli A, Debernardi-Venon W, Alessandria C, Franchello A, Salizzoni M, Rizzetto M. Liver Transpl; 2005 Apr 10; 11(4):402-9. PubMed ID: 15776431 [Abstract] [Full Text] [Related]
38. Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation. Singer GA, Zielsdorf S, Fleetwood VA, Alvey N, Cohen E, Eswaran S, Shah N, Chan EY, Hertl M, Fayek SA. Transplant Proc; 2015 Mar 10; 47(2):478-84. PubMed ID: 25769595 [Abstract] [Full Text] [Related]